Skip to content
lifestyle.usfeatures.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Relay Therapeutics, Inc.
Relay Therapeutics to Participate in Two Upcoming Investor Conferences in September
September 2, 2026
Relay Therapeutics Reports Second Quarter 2026 Financial Results and Corporate Updates
August 6, 2026
Relay Therapeutics to Announce Second Quarter 2026 Financial Results and Corporate Highlights on August 6, 2026
July 30, 2026
Relay Therapeutics to Participate in Two Upcoming Investor Conferences in June
May 27, 2026
Relay Therapeutics Announces Pricing of Public Offering of Common Stock
May 24, 2026
Relay Therapeutics Announces Proposed Public Offering of Common Stock
May 24, 2026
Relay Therapeutics Announces Initial Clinical Data Demonstrating That Zovegalisib Has Potential for Differentiated Safety and Efficacy in Patients with PIK3CA-Driven Vascular Anomalies
May 24, 2026
Relay Therapeutics Reports First Quarter 2026 Financial Results and Corporate Updates
May 21, 2026
Relay Therapeutics to Announce First Quarter 2026 Financial Results and Corporate Highlights on May 5, 2026
April 29, 2026
Relay Therapeutics Announces Clinical Data for Zovegalisib plus Atirmociclib Triplet Combination Supportive of Further Development in Frontline Metastatic Breast Cancer
April 29, 2026
1
2
Next Page
→